Home

Home

TOP INDUSTRY NEWS

J&J’s CEO To Take On Additional Role as Chairman
By
- Jacob White
December 1, 2022
Teva Names Ex-Sandoz Executive as New CEO and President
By
- Jacob White
December 1, 2022
Viatris Completes Sale of Biosimilars Biz to Biocon in $3.3-Bn Deal
By
- Jacob White
December 1, 2022
Novo Nordisk Investing $742 M To Expand Clinical-Scale API Mfg
By
- Jacob White
December 1, 2022
Merck & Co. To Acquire Imago BioSciences for $1.35 Bn
By
- Jacob White
December 1, 2022
Supplier News: Cambrex, WuXi STA, Fujifilm & More
By
- Jacob White
December 1, 2022

Features

The Year in Review: The Top 10 News Developments from 2022
By
- Patricia Van Arnum
Escalating energy and raw materials costs was the number one story in the bio/pharmaceutical industry in 2022, but what other news was noteworthy in deal-making, expansions, and industry performance. DCAT Value Chain Insights provides its Top 10 News Stories of 2022.

December 1, 2022
Value-Added Medicines: A Call in the EU for a New Drug Class
By
- Patricia Van Arnum
Akin to the 505 (B)(2) pathway in the US, Medicines for Europe is calling on EU authorities to recognize value-added medicines as separate group of medicines in EU legislation with new approval procedures, innovation frameworks and reimbursement processes.

December 1, 2022

SPONSORED CONTENT
Balancing Innovation and Industrialization in a Growth Company—Reflecting on 2022 with Nanoform’s Chief Commercial Officer Christian Jones
- Sponsored By Nanoform
November 22, 2022
SPONSORED CONTENT
Olon and Particle Engineering
- Sponsored By Olon SpA
October 14, 2022
SPONSORED CONTENT
Small is Powerful: A Globally Unique Capability for Nanoforming HPAPIs
- Sponsored By Nanoform
October 6, 2022

DCAT MEMBER COMPANY COMMUNITY

New Member Company Alert
By
Miranda
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. From the December 2, 2022 issue of DCAT Value Chain Insights:…

November 30, 2022
Women Leaders in Pharma Interview: Lillie Talon, Catalent Pharma Solutions
By
Miranda
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Lillie Talon, Cell Therapy Proposal Lead, Catalent Pharma Solutions. Read her interview here. …

November 22, 2022
DCAT Alliance for Industry Women Committee To Present Zoom Panel on Excelling in a Multigenerational Workplace
By
Miranda
The DCAT Alliance for Industry Women Committee will present a live panel discussion on Tuesday, December 13, 2022, that will showcase three industry women of different ages who will discuss…

November 17, 2022
People on the Move
By
Eugene
Here are the latest moves and promotions of employees of our DCAT Member Company community. To submit a request to be included in People on the Move, click here. From…

November 17, 2022